Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Support for the concept that herpes simplex virus type 1 (HSV1), when present in the brains of apolipoprotein E‐«4 carriers, is a major risk for Alzheimer's disease (AD) is increasing steadily, with over 120 publications providing direct or indirect evidence relevant to the hypothesis. No articles have contested the concept, apart from 3 published 13–18 yr ago. This review describes very recent studies on the role of HSV1 but refers also to older studies that provide background for some lesser‐known related topics not covered in other recent reviews; these include the relevance of herpes simplex encephalitis and of epilepsy to AD, the action of IFN, and the possible relevance of the different types of DNA damage to AD—in particular, those caused by HSV1—and mechanisms of repair of damage. New epidemiologic data supporting previous studies on mild cognitive impairment and progression to AD are reviewed, as are those examining the relationship between total infectious burden (additive seropositivity to various microbes) and cognition/AD. The latter indicates the involvement of HSV1 and cytomegalovirus (and the necessity of taking into account any marked differences in sensitivity of antibody detection). Recent studies that provide further support for the occurrence of repeated reactivation of latent HSV1 in the brain in AD pathogenesis are also discussed.—Itzhaki, R. F. Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts. FASEB J . 31, 3216–3226 (2017). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · cited 2×
“Based on animalmodels of AD and on the observations cited above, Palop and Mucke (73) have suggested that aberrant excitatory activity caused by Ab, together with other age-related changes, might contribute to the cognitive deficits observed in the animals and that similar changes might explain the impaired cognition…”
The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540 · cited 2×
“What are the roles of Ab and P-tau, especially considering the proposal by Braak and Del Tredici (126), from anatomic considerations, that extracellular and aggregated Ab might be produced by abnormal P-tau, the latter causedby apathogen that, they suggest, isHSV1?”
Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques
Wozniak, M., Mee, A., & Itzhaki, R. (2009) · The Journal of Pathology · doi:10.1002/path.2449 · Cited by 464
Self-citationWeissman, L., Jo, D.-G., Sorensen, M. M., de Souza-Pinto, N. C., Markesbery, W. R., Mattson, M. P., & Bohr, V. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm605 · Cited by 299
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
Ittner, A., Chua, S. W., Bertz, J., Volkerling, A., van der Hoven, J., Gladbach, A., Przybyla, M., Bi, M., van Hummel, A., Stevens, C. H., et al. (2016) · Science · doi:10.1126/science.aah6205 · Cited by 263 · cited 1×
“And how does another recent study (122) that suggests that site-specific P-tau inhibits Ab toxicity relate to the antiviral action of Ab (123–125)? What are the roles of Ab and P-tau, especially considering the proposal by Braak and Del Tredici (126), from anatomic considerations, that extracellular and aggregated Ab…”
Meta-analysis of Telomere Length in Alzheimer’s Disease
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw053 · Cited by 229
The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years
Aiello, A. E., Haan, M. N., Blythe, L., Moore, K., Gonzalez, J. M., & Jagust, W. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00796.x · Cited by 210 · cited 1×
“(46) studied a subset (1204/1789) of participants in the Sacramento Area Latino Study on Aging, aged 60–100, and reported that the rate of cognitive decline varied significantly over a 4-yr period (even allowing for age, education, sex, and chronic health conditions) with the level of anti-CMVantibodybut notwith that…”
Bourgade, K., Garneau, H., Giroux, G., Le Page, A. Y., Bocti, C., Dupuis, G., Frost, E. H., & Fülöp, T. (2015) · Biogerontology · doi:10.1007/s10522-014-9538-8 · Cited by 208
Cited by
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
De Chiara, G., Piacentini, R., Fabiani, M., Mastrodonato, A., Marcocci, M. E., Limongi, D., Napoletani, G., Protto, V., Coluccio, P., Celestino, I., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007617 · Cited by 266
Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease
Itzhaki, R. F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00324 · Cited by 256
Self-citationA 3D human brain–like tissue model of herpes-induced Alzheimer’s disease
Cairns, D. M., Rouleau, N., Parker, R. N., Walsh, K. G., Gehrke, L., & Kaplan, D. L. (2020) · Science Advances · doi:10.1126/sciadv.aay8828 · Cited by 247
“There is increasing evidence to suggest a clinical correlation between pathogens such as herpes and the development of sporadic AD (20, 21), including the findings that HSV-1 DNA was detected in the brain tissue of patients with AD (24–26) and recent epidemiological studies even reporting HSV-1 infection as a signific…”
BackgroundThe Microbiome as a Modifier of Neurodegenerative Disease Risk
Fang, P., Kazmi, S. A., Jameson, K. G., & Hsiao, E. Y. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.008 · Cited by 226
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Alzheimer disease and the periodontal patient: New insights, connections, and therapies
Ryder, M. I., & Xenoudi, P. (2021) · Periodontology 2000 · doi:10.1111/prd.12389 · Cited by 55
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51
Roles of HSV-1 infection-induced microglial immune responses in CNS diseases: friends or foes?
Wang, Y., Jia, J., Wang, Y., Li, F., Song, X., Qin, S., Wang, Z., Kitazato, K., & Wang, Y. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1660615 · Cited by 40
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201534 · Cited by 37
“These infections included herpes labialis or genitalis ( Herpes simplex virus ) [9], cytomegalovirus related hepatitis, retinitis, colitis, mononucleosis, or other infections [10], Lyme disease ( Borrelia burgdorferi ) [11, 24], gingivitis ( Porphyromonas gingivalis ) [12], urinary tract infections…”
Common vaccines and the risk of incident dementia: a population-based cohort study
Douros, A., Ante, Z., Suissa, S., & Brassard, P. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac484 · Cited by 24
Wang, Y., Luo, W., Wang, X., Ma, Y., Huang, L., & Wang, Y. (2022) · Journal of Infection · doi:10.1016/j.jinf.2021.12.004 · Cited by 17
Metadata
- Authors
- Itzhaki, R. F.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2017-07-10
- Volume
- 31
- Issue
- 8
- Pages
- 3216-3226
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2740041460
- Cited by
- 118
- References
- 17
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.